Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Merck
Cantor Fitzgerald
Colorcon
Deloitte
Mallinckrodt

Generated: September 23, 2019

DrugPatentWatch Database Preview

Patent: 9,351,940

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,351,940
Title:Nanoparticles comprising esters of poly (methyl vinyl ether-co-maleic anhydride) and uses thereof
Abstract: The present invention relates to nanoparticles for encapsulating compounds, the preparation and uses thereof, said nanoparticles being based on half (C.sub.1-C.sub.4) alkyl esters of poly (methyl vinyl ether-co-maleic anhydride) (PVM/MA) copolymers. Said nanoparticles can encapsulate or incorporate a product of interest for use in the agricultural, cosmetic, food or pharmaceutical fields.
Inventor(s): Salman; Hesham H. A. (Noain-Navarra, ES), Goni Azcarate; Izaskun (Pamplona, ES)
Assignee: BIONANOPLUS, S.L. (Noain-Navarra, ES)
Application Number:14/111,855
Patent Claims:see list of patent claims

Details for Patent 9,351,940

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26 ➤ Sign Up BIONANOPLUS, S.L. (Noain-Navarra, ES) 2031-04-15 RX search
Centocor Inc REMICADE infliximab VIAL 103772 001 1998-08-24 ➤ Sign Up BIONANOPLUS, S.L. (Noain-Navarra, ES) 2031-04-15 RX Orphan search
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25 ➤ Sign Up BIONANOPLUS, S.L. (Noain-Navarra, ES) 2031-04-15 RX Orphan search
Genentech XOLAIR omalizumab VIAL 103976 001 2003-06-20 ➤ Sign Up BIONANOPLUS, S.L. (Noain-Navarra, ES) 2031-04-15 RX search
Abbvie Inc HUMIRA adalimumab SYRINGE 125057 001 2002-12-31 ➤ Sign Up BIONANOPLUS, S.L. (Noain-Navarra, ES) 2031-04-15 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Deloitte
Express Scripts
QuintilesIMS
Chinese Patent Office
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.